| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/16/1999 | US5883075 Hypotensive agent cyclic peptides |
| 03/16/1999 | US5882703 Product containing Mortierella sect. schmuckeri lipids |
| 03/16/1999 | US5882656 Useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, paget's disease, malignant hypercalcemia, and |
| 03/16/1999 | CA2165012C Estrogen agonists |
| 03/16/1999 | CA2158108C Compositions containing sertraline and a 5-ht1d receptor agonist or antagonist |
| 03/16/1999 | CA2090186C Method of treatment of hiv-seropositive individuals with dietary whey proteins |
| 03/16/1999 | CA2008825C Reg protein |
| 03/12/1999 | WO1998009637A2 Treatment of diabetes |
| 03/12/1999 | CA2264774A1 Treatment of diabetes |
| 03/12/1999 | CA2246928A1 Novel phthalaldehyde derivatives, process for their preparation, and their use |
| 03/11/1999 | WO1999011778A1 Antisense treatment of pulmonary hypertension |
| 03/11/1999 | WO1999011759A1 GLUCOSE RESPONSIVE β-CELL LINE |
| 03/11/1999 | WO1999011649A2 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same |
| 03/11/1999 | WO1999011645A1 Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 03/11/1999 | WO1999011628A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity |
| 03/11/1999 | WO1999011620A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors |
| 03/11/1999 | WO1999011606A2 Inhibitors of protein tyrosine phosphatase |
| 03/11/1999 | WO1999011263A1 Combination therapy comprising amlodipine and a statin compound |
| 03/11/1999 | WO1999011260A1 Combination therapy comprising atorvastatin and an antihypertensive agent |
| 03/11/1999 | WO1999011259A1 Therapeutic combinations comprising amlodipin and atorvastatin |
| 03/11/1999 | WO1998054212A3 Human type 3 ryanodine receptor protein and dna molecules coding therefor |
| 03/11/1999 | CA2302830A1 Glucose responsive .beta.-cell line |
| 03/11/1999 | CA2302167A1 Antisense treatment of pulmonary hypertension |
| 03/11/1999 | CA2298601A1 Inhibitors of protein tyrosine phosphatase |
| 03/11/1999 | CA2296723A1 Combination therapy comprising atorvastatin and an antihypertensive agent |
| 03/11/1999 | CA2294133A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 03/11/1999 | CA2294110A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity |
| 03/11/1999 | CA2294074A1 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same |
| 03/10/1999 | EP0900272A2 Tumor necrosis factor alpha convertase |
| 03/10/1999 | EP0900225A1 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
| 03/10/1999 | EP0900199A1 Azetidinone derivatives for the treatment of atherosclerosis |
| 03/10/1999 | EP0900185A1 Vitamin d analogs and methods of preparing these compounds |
| 03/10/1999 | EP0900083A1 Novel substituted imidazole compounds |
| 03/10/1999 | EP0900077A1 Serum cholesterol lowering agent |
| 03/10/1999 | EP0785769B1 Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof |
| 03/10/1999 | EP0677039B1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase |
| 03/10/1999 | CN1210469A Mixtures derived from eugenia jambolana lamarck, preparation and use of said mixtures and some of their constituents as medicaments |
| 03/10/1999 | CN1210012A Transcription for defatting health-care products and preparation thereof |
| 03/09/1999 | US5880263 Human chemotactic protein |
| 03/09/1999 | US5880208 Polymer compounds |
| 03/09/1999 | US5880151 Treating or preventing disease characterized by high levels of low density lipoprotein particles or cholesterol in blood |
| 03/09/1999 | US5880148 Treating diabetes, arterial hypertension, restenosis and atheromatous diseases |
| 03/09/1999 | US5880141 Controlling, modulating and inhibiting tyrosine kinase signal transduction |
| 03/09/1999 | US5880095 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents |
| 03/09/1999 | US5879908 CRFG-1a, a target and marker for chronic renal failure |
| 03/09/1999 | US5879698 Calcium dietary supplement |
| 03/09/1999 | US5879688 Treatment of skin disorders, wrinkling, aging |
| 03/09/1999 | US5879680 Cloned DNA for synthesizing unique glucocerebrosidase |
| 03/09/1999 | CA2131831C The use of quinoline-3-carboxamide compounds for treatment of diabetes |
| 03/09/1999 | CA1340430C Preparation of antihypercholesterolemic tetrazole compounds and intermediates thereof |
| 03/08/1999 | CA2242476A1 Novel compositions containing cyclosporin |
| 03/04/1999 | WO1999010492A1 Adipocyte-specific protein homologs |
| 03/04/1999 | WO1999010330A1 Heterocyclic ketones as npy y5 antagonists |
| 03/04/1999 | WO1999010325A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases |
| 03/04/1999 | WO1999010002A1 A method for treating diabetes, hyperglycemia and hypoglycemia |
| 03/04/1999 | CA2301821A1 Heterocyclic ketones as npy y5 antagonists |
| 03/04/1999 | CA2301660A1 Adipocyte-specific protein homologs |
| 03/03/1999 | EP0899332A2 The G-protein coupled receptor HFIAO41 |
| 03/03/1999 | EP0899261A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists |
| 03/03/1999 | EP0898900A2 Composition and method for providing nutrition to diabetics |
| 03/03/1999 | EP0898478A1 Stimulation of host defence mechanisms against tumors |
| 03/03/1999 | EP0731791B1 benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 03/03/1999 | EP0724570B1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 03/03/1999 | EP0674641B1 Pyrrolopyrimidines as crf antagonists |
| 03/03/1999 | CN1209729A Food and vitamin products containing natural isomer of reduced folates |
| 03/03/1999 | CN1209322A Series product of high-effective neutral calcium-supplementary preparation |
| 03/03/1999 | CN1042329C Substituted cyclohexane derivative for curing diseases |
| 03/03/1999 | CN1042328C Substituted cyclohexane derivative and medicine containing same |
| 03/02/1999 | US5877290 Humanized antibody fragment that binds a polypeptide sequence encoded by cdna of an anti-hypercalcemic hormone; treatment of electrolyte disorders, kidney failure, bone and heart disorders, osteoporosis, paget's disease |
| 03/02/1999 | US5877208 Naringin and naringenin as 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase inhibitor |
| 03/02/1999 | US5877207 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/02/1999 | US5876968 Mixture of disulfide bonded dimer of al-milano, lipid lowering agent, and carrier; drug for treatment of athlerosclerosis and cardiovascular disease; prodrug for monomer; prevention of thrombosis |
| 03/02/1999 | CA2175458C Novel benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 02/25/1999 | WO1999009052A1 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 02/25/1999 | WO1999009024A1 Phenyl urea and phenyl thiourea derivatives as hfgan72 antagonists |
| 02/25/1999 | WO1999008708A2 Method and food product for increasing muscle protein and reducing fat in animals |
| 02/25/1999 | WO1999008682A1 A method of preventing or treating estrogen-dependent diseases and disorders |
| 02/25/1999 | WO1999008660A1 Solid pharmaceutical dosage forms in form of a particulate dispersion |
| 02/25/1999 | WO1999008551A1 A food supplement composition based on dehydrated crab meat |
| 02/25/1999 | WO1998053050A3 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 02/25/1999 | WO1998047866A3 Arylsecocholadiene derivatives |
| 02/25/1999 | WO1998046243A3 Pharmaceutical compositions having appetite suppressant activity |
| 02/25/1999 | WO1998032017A3 Modulators of insulin receptor activity |
| 02/25/1999 | CA2300178A1 Phenyl urea and phenyl thiourea derivatives as hfgan72 antagonists |
| 02/25/1999 | CA2300056A1 A food supplement composition based on dehydrated crab meat |
| 02/25/1999 | CA2299291A1 Method and food product for increasing muscle protein and reducing fat in animals |
| 02/24/1999 | EP0897980A2 CXCR4B: A human splice variant of CXCR4 chemokine receptor |
| 02/24/1999 | EP0897912A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 02/24/1999 | EP0897390A1 Human tumor necrosis factor delta and epsilon |
| 02/24/1999 | CN1209122A Preventives/remedies for complication of diabetes |
| 02/24/1999 | CN1209119A Novel tricyclic compounds and drug compositions contg. same |
| 02/24/1999 | CN1209064A Combination therapy for osteoporosis |
| 02/24/1999 | CN1209058A Aminoguanidine for treating NIDOM |
| 02/24/1999 | CN1209057A Nitric oxide (NO) synthase inhibitor to treat or prevent type II diabetes |
| 02/24/1999 | CN1208650A Novel medicine for treating diabetes |
| 02/23/1999 | US5874611 A chemical intermediate for chroman derivatives useful as a blood sugar-lowering agent |
| 02/23/1999 | US5874573 Cyclic amine derivatives |
| 02/23/1999 | US5874535 Human leptin receptor gene-related protein |
| 02/23/1999 | US5874454 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| 02/23/1999 | US5874451 Hypolipidemic agents |